Endoplasmic reticulum (ER) α-glucosidase I is an enzyme that trims the distal α1,2-linked glucose (Glc) residue from the Glc 3 Man 9 GlcNAc 2 oligosaccharide following its addition to nascent glycoproteins in the initial step of processing. This reaction is critical to the subsequent processing of N-glycans and thus defects in α-glucosidase I gene in human cause congenital disorder of glycosylation (CDG) type IIb. We identified the Caenorhabditis elegans α-glucosidase I gene (F13H10.4, designated agl-1) that encodes a polypeptide with 36% identity to human α-glucosidase I. The agl-1 cDNA restored the expression of complex-type N-glycans on the cell surface of α-glucosidase I-defective Chinese hamster ovary Lec23 cells. RNAi knockdown of agl-1 [agl-1(RNAi)] produced worms that were visibly similar to wild-type, but lifespan was reduced to about half of the control. Analyses of N-glycosylation in agl-1(RNAi) animals by western blotting and mass spectrometry showed reduction of paucimannose and complex-type glycans and dramatic increase of glucosylated oligomannose glycans. In addition, a significant amount of unusual terminally fucosylated N-glycans were found in agl-1(RNAi) animals. ER stress response was also provoked, leading to the accumulation of large amounts of triglucosylated free oligosaccharides (FOSs) (Glc 3 Man 4-5 GlcNAc 1-2 ) in agl-1(RNAi) animals. Acceleration of ER-associated degradation in response to the accumulation of unfolded glycoproteins and insufficient interaction with calnexin/ calreticulin in the ER lumen likely accounts for the increase of FOSs. Taken together, these studies in C. elegans demonstrate that decreased ER α-glucosidase I affects the entire N-glycan profile and induces chronic ER stress, which may contribute to the pathophysiology of CDG-IIb in humans.
Introduction N-Glycosylation is one of the major co-and posttranslational modifications of proteins, and plays important roles in protein folding and quality control as well as in conferring stability to the proteins under physiological conditions (Helenius and Aebi 2001) . In eukaryotic cells, N-glycosylation begins with en bloc transfer of Glc 3 Man 9 GlcNAc 2 moiety from lipid-linked oligosaccharide onto Asn residue of Asn-Xxx-Ser/Thr/Cys sequon (where Xxx is any amino acid except Pro) in the nascent polypeptides by the oligosaccharyltransferase complex in the luminal side of the endoplasmic reticulum (ER) membrane. Most N-linked oligosaccharides are subjected to further processing by the ER/Golgi-resident α-glucosidases and α-mannosidases, and are subsequently converted into hybrid-or complex-type glycans by a variety of glycosyltransferases and modifying enzymes in the Golgi. Although the former part of the glycan-processing pathway is likely common in most eukaryotes, the latter part is diversified widely depending on which species, organs and tissues express any particular glycoprotein.
In the last few decades, many studies have described the importance of N-glycosylation, particularly in regard to the early processing pathway's function in protein folding and quality control (Helenius and Aebi 2004) . In the initial steps of N-glycan processing, ER α-glucosidase I (mannosyl-oligosaccharide glucosidase or processing α-glucosidase I; EC 3.2.1.106) trims the distal α1,2-linked glucose (Glc) from the Glc 3 Man 9 GlcNAc 2 oligosaccharide after its addition to the nascent protein, and ER α-glucosidase II subsequently removes a α1,3-linked Glc residue, resulting in a monoglucosylated structure (Glc 1 Man 9 GlcNAc 2 ). This structure is recognized by the ER chaperone proteins calnexin/calreticulin for proper folding of the polypeptide in concert with the co-chaperone oxidoreductase ERp57 (Zapun et al. 1998) . A Glc residue on the monoglucosylated structure is then removed by ER α-glucosidase II to release the protein from calnexin/calreticulin for further glycan processing. However, re-glucosylation occurs on the glycans of improperly folded glycoproteins by UDP-Glc:glycoprotein glucosyltransferase, allowing the incompletely folded protein to re-interact with calnexin/calreticulin (Sousa et al. 1992) . Proteins that are not productively folded are eventually eliminated from this calnexin/calreticulin cycle and their glycans are trimmed by ER α-mannosidase I and EDEM1/2/ 3, thereby exposing α1,6-linked Man residue on the C-branch, which is in turn recognized by ER-lectins such as OS-9 (Clerc et al. 2009; Hosokawa et al. 2010) . This leads to the retrotranslocation and disposal of the unfolded protein by the ER-associated degradation (ERAD) process (Ruddock and Molinari 2006; Maattanen et al. 2010; Xie and Ng 2010) . Thus, a number of glycan-interacting proteins participate in the protein quality control machinery and each glycan structure has significant physiological meaning. Therefore, defects in proper glycan processing could lead to accumulation of immature unfolded glycoproteins in the ER, thereby activating an ER-to-nucleus signaling cascade collectively termed the unfolded protein response (UPR) to relieve this ER stress Sidrauski et al. 1996; Mori 2000) . During ERAD, the glycans on unfolded proteins are released by peptide:N-glycanase (PNGase) and are subsequently degraded by endo-β-N-acetylglucosaminidase (ENGase) in the cytosol (Kato, Kitamura et al. 2007; Suzuki 2007; Chantret and Moore 2008) . These free oligosaccharides (FOSs) in the cytosol are transported to the lysosome where they are degraded into monosaccharides.
Decreased ER α-glucosidase I activity in humans causes a severe congenital disorder of glycosylation (CDG) type IIb, which is characterized by dysmorphism, seizures, hepatomegaly, hepatic fibrosis and death at 2.5 months (De Praeter et al. 2000) . In CDG-IIb patients, the abundance of unprocessed glucosylated high-mannose (Man) N-glycan structures was increased on glycoproteins and free Glc 3 Man 1 oligosaccharides produced by the action of endo-α1,2-mannosidase were detected in urine (De Praeter et al. 2000; Volker et al. 2002) . Similar glycanprocessing defects were obtained by using α-glucosidase I-deficient Lec23 Chinese hamster ovary (CHO) cells (Ray et al. 1991; Hong et al. 2004 ) and by treating mammalian cells with α-glucosidase inhibitors (Durrant and Moore 2002; Mellor et al. 2004) . Additionally, accumulation of glucosylated FOSs in the cytosol has been reported in these cells (Durrant and Moore 2002; Mellor et al. 2004; Alonzi et al. 2008) , which is a characteristic feature of ER α-glucosidase I deficiency.
Caenorhabditis elegans is a suitable model organism for studying N-glycan processing and associated cellular events because its N-glycan structures have been characterized (Cipollo et al. 2002; Natsuka et al. 2002; Haslam and Dell 2003; Hanneman et al. 2006) . Also, our previous study expanded the value of this organism in glycobiology by characterizing the FOS structures of C. elegans (Kato, Kitamura et al. 2007 ). Here, we identify the C. elegans ER α-glucosidase I gene (designated agl-1). Knockdown of agl-1 by RNAi results in increased unprocessed N-glycans, up-regulation of ER stress response and accumulation of glucosylated FOSs. We also detected and characterized unusual fucosylated structures on glycoproteins in the agl-1 knockdown worms.
Results
Identification of the gene encoding ER α-glucosidase I in C. elegans To identify the ER α-glucosidase I in C. elegans, we searched the genomic database using human ER α-glucosidase I (hGCS1) as a query (Kalz-Fuller et al. 1995) . We found a protein encoded by the gene F13H10.4 showing 36% identity in amino acid sequence with hGCS1. The protein is predicted to be a type II transmembrane protein with a large C-terminal region containing a glycoside hydrolase family 63 domain, which should be oriented into the ER lumen. We amplified the cDNA by reverse transcription-polymerase chain reaction (RT-PCR) using mRNA from C. elegans as a template and sequenced the resulting product. The cDNA encodes 799 amino acid residues and is a hybrid form of F13H10.4a and c isoforms reported in WormBase (http://www.wormbase.org/, last accessed 20 June 2013), namely the first exon of F13H10.4a consisting of a 5′-untranslated region connected to F13H10.4c. The amino acid residues whose substitutions lead to reduction of ER α-glucosidase I activity in mammals are conserved in F13H10.4 (Supplementary data, Figure S1 ). We transiently transfected CHO Lec23 cells, which are defective in ER α-glucosidase I, with the cloned F13H10.4 cDNA and analyzed the surface expression of complex N-glycans using fluorescein isothiocyanate (FITC)-labeled L-phytohaemagglutinin α-Glucosidase I from Caenorhabditis elegans (PHA) lectin ( Figure 1A ). F13H10.4 cDNA partially restored the expression of complex N-glycans in CHO Lec23 cells, suggesting that this gene is a functional homolog of mammalian ER α-glucosidase I. Therefore, we named F13H10.4 gene agl-1 (alpha-glucosidase I).
Knockdown of agl-1 in C. elegans by RNAi To investigate the consequence of reduced agl-1 in C. elegans, we knocked down the gene by feeding RNAi. Wild-type worms were fed Escherichia coli expressing double-stranded RNA of agl-1. The expression level of agl-1 gene in RNAi knockdown of agl-1 [agl-1(RNAi)] worms was compared with that in mock control by semi-quantitative RT-PCR, and was found to be reduced to less than 10% of the control ( Figure 1B) .
We continuously fed wild-type worms with E. coli expressing the RNAi construct but observed no visible morphological phenotype and detected no significant differences in the number of laid eggs and hatching rates. However, agl-1(RNAi) lifespan was shortened to less than half of the mock control and the relative difference between the populations was maintained at both 20 and 25°C ( Figure 1C ).
Effect of agl-1 knockdown on N-glycosylation Since ER α-glucosidase I is an essential processing enzyme in the N-glycosylation pathway, knockdown of agl-1 gene is anticipated to directly impact on the N-glycome of the organism. Worm N-glycans have been previously characterized by several groups (Altmann et al. 2001; Cipollo et al. 2002 Cipollo et al. , 2005 Natsuka et al. 2002; Haslam and Dell 2003; Paschinger et al. 2004; Hanneman et al. 2006; Schachter 2009 ) and comprise six groups based on structural characteristics: Oligomannosidic, paucimannosidic, truncated complex, fucose (Fuc)-rich, phosphorylcholine (PC)-rich and core chitobiose modified glycans (Paschinger et al. 2008) . In order to evaluate the effect of agl-1 knockdown on N-glycans, we first performed western blotting using antihorseradish peroxidase (HRP) antibody, which recognizes mature-type core α1,3-fucosylated N-glycans (Paschinger et al. 2004 (Paschinger et al. , 2009 ). As expected, tunicamycin (TM) treatment greatly reduced the reactivity of anti-HRP antibody toward total glycoproteins. The reactivity of glycoproteins harvested from agl-1(RNAi) worms was also reduced in comparison with control worms, although the reduction was less than what was detected following TM treatment; the result is nevertheless still compatible with agl-1(RNAi) having an effect on N-glycan processing ( Figure 1D ).
N-Glycosylation changes in agl-1(RNAi) worms were further investigated by mass spectrometry (MS). N-Glycans were released from wild-type and agl-1(RNAi) glycoproteins by hydrazinolysis because it releases glycans with core chitobiose modifications (e.g. hexose (Hex) extension on the core α1,3-linked Fuc) that could be resistant to digestion by PNGase-F and -A (Hanneman et al. 2006) . The released glycans were permethylated and analyzed by nanospray-ionization (NSI)-MS n using an LTQ/Orbitrap mass spectrometer. We assigned 36 molecular ions corresponding to oligomannosidic, paucimannosidic, truncated complex and Fuc-rich N-glycans from control and agl-1(RNAi) worms, but PC-rich glycans were not detected presumably due to loss of those during the permethylation protocol (Figure 2 and Supplementary data, Table S1 ). In the full MS profile of agl-1(RNAi) worms, relative abundances of molecular ions at m/z 1312, 1414 and 1516, which correspond to the masses of doubly charged ions of sodium adducts of Hex 10 HexNAc 2 , Hex 11 HexNAc 2 and Hex 12 HexNAc 2 , respectively, were dramatically increased in comparison with those from control worms. These structures were annotated to be glucosylated oligomannosidic glycans (Glc 1-3 Man 7-9 GlcNAc 2 ) based on the Hex content predicted by their compositional mass. These glucosylated oligomannosidic glycans accounted for up to 51% of the total profile in agl-1(RNAi) worms, but only 3.4% of the total profile in control worms. In contrast, the relative amounts of further trimmed oligomannosidic (Hex 5-9 HexNAc 2 ), paucimannosidic and core fucosylated (Hex 3-4 HexNAc 2 , dHex 1 Hex 3-5 HexNAc 2 and dHex 2 Hex 4-5 HexNAc 2 ) glycans were significantly decreased in agl-1(RNAi) worms. The reduction of dHex 2 Hex 4-5 HexNAc 2 glycans is consistent with the reduced anti-HRP antibody reactivity detected by western blotting. These results indicate that knockdown of agl-1 shifts N-glycan processing away from the production of complex-type structures and toward increased prevalence of glucosylated oligomannosidic forms.
Glycomic analyses detected the accumulation of previously undescribed, oligo-Hex structures modified with a single deoxyhexose (dHex) residue at the nonreducing terminal, dHex 1 Hex 9-11 HexNAc 2 , in agl-1(RNAi) worms (Figure 2 and Supplementary data, Table S1 ). MS 2 fragmentation at m/z 1501 (doubly charged ion of dHex 1 Hex 11 HexNAc 2 , the most abundant dHex-modified oligo-Hex structure) produced a fragment ion at m/z 1362, corresponding to the loss of HexNAc at the reducing end. This loss of a single N-acetylhexosamine (HexNAc) from the reducing terminus indicates that the dHex residue was not attached to the core chitobiose structure ( Figure 3A ). The MS 2 profile at m/z 1501 also exhibits the fragment ion m/z 1027, corresponding to dHex 1 Hex 4 . Furthermore, the m/z 707 MS 3 fragment ion (1501-1027-707) is assigned as the 3, 5 A cross-ring cleavage through the α1,6-linked Man residue of the core structure, which is a diagnostic fragment indicating that the C-branch (the branch of Manα1-6Manα1-6Manβ) is modified with the dHex ( Figure 3B ) (Ashline et al. 2005) . Finally, the MS 3 fragment ion at m/z 839 (1501-1027-839) corresponds to the loss of nonreducing terminal dHex (−188). Taken together, MS n analyses indicate that a dHex is attached to a terminal Hex in the C-branch of glucosylated oligomannosidic structures in agl-1 (RNAi) worm glycoproteins.
Knockdown of agl-1 causes upregulation of ER stress response Impaired N-glycan processing often inhibits calnexin/calreticulindependent protein quality control, resulting in the accumulation of unfolded glycoproteins in the ER and the activation of signaling pathways that induce the UPR. The UPR is characterized by the induced expression of an array of genes that help to attenuate the translation rate, facilitate protein folding and degrade unfolded proteins through ERAD. Heat shock protein 4 (HSP-4), an ER chaperone, is one of the proteins induced by the UPR, and is a marker for ER stress (Calfon et al. 2002) . Inhibition of N-glycosylation by TM induced the expression of green fluorescence protein (GFP)-tagged HSP-4 (hsp-4::gfp), detected by fluorescence microscopy and by western blotting ( Figure 4A and B). Knockdown of agl-1 showed a similarly significant induction T Katoh et al. of HSP-4::GFP ( Figure 4A and B), indicating that α-glucosidase I deficiency causes ER stress in C. elegans.
Triglucosylated FOSs accumulate in the cytosol of agl-1 knockdown worms Since agl-1 knockdown strongly induced UPR, ERAD of unfolded glycoproteins should be upregulated. During ERAD, N-linked glycans are cleaved from polypeptides by PNGase and are subsequently processed by ENGase and α-mannosidase in the cytosol (Suzuki et al. 2000 (Suzuki et al. , 2006 Blom et al. 2004; Kato, Kawahara et al. 2007; Kato, Kitamura et al. 2007; Chantret and Moore 2008) . Unlike mammalian cells, C. elegans lacks a cytosolic α-mannosidase (Kato, Kitamura et al. 2007 ). Therefore, FOSs should retain the nonreducing end structure that the glycoprotein glycan possessed before the unfolded glycoprotein was retro-translocated to the cytosol from the ER. We analyzed FOSs extracted from agl-1(RNAi) and mock control by MS. We Fig. 2 . Analyses of the N-linked glycans from agl-1(RNAi) and mock-treated N2 worms. N-Linked glycans were released from glycoproteins by hydrazinolysis, re-N-acetylated and permethylated. Permethylated glycans were analyzed using NSI-MS n (LTQ-Orbitrap). (A) Full MS profiles from the control (upper) and agl-1 (RNAi) (lower) in a range of m/z from 1000 to 1600. Major glycan peaks are annotated with the predicted glycan structures. (B) Quantification of the prevalence of each N-linked glycan structure. Based on the intensities of glycan signals for each structure, the prevalence of each glycan was quantified as percentage of the total glycan intensity. The averages of three independent experiments with standard errors are shown. Asterisks indicate the significance between control and agl-1(RNAi) worms in two-tailed student t-test. *P < 0.05, **P < 0.01 and ***P < 0.001. α-Glucosidase I from Caenorhabditis elegans detected a series of molecular ions corresponding to the masses of predicted FOSs in control worms ( Figure 5A and Supplementary data, Table S2 ). Based on peak intensities measured in full MS profiles, the amount of each structure was measured for two sets of FOS species: FOSs with a single GlcNAc (FOS-GN1) and with two GlcNAc (FOS-GN2) at their reducing ends ( Figure 5B ). FOS-GN2 species are primarily generated by the action of PNGase, and then converted into FOS-GN1 species by the action of ENGase (Kato, Kitamura et al. 2007 ). In the FOS-GN1 species from the control, short truncated structures (Hex 2-3 HexNAc 1 ) were relatively abundant, followed by oligomannosidic species, in the order of Hex 5 HexNAc 1 , Hex 4 HexNAc 1 , Hex 6 HexNAc 1 , Hex 7 HexNAc 1 , Hex 8 HexNAc 1 and Hex 9 HexNAc 1 . In agl-1(RNAi) worms, FOS-GN1 species were increased. In particular, Hex 7-8 HexNAc 1 structures were most dramatically increased compared with control.
MS n analyses were performed to assign the structures of the FOS species that were increased in the agl-1(RNAi) worms (Supplementary data, Figures S2 and S3 ). The MS 2 spectrum of Hex 7 HexNAc 1 (m/z 1742) from agl-1(RNAi) gave fragment ions at m/z 1261, corresponding to Hex 6 and m/z 504, corresponding to Hex 1 HexNAc 1 (Supplementary data, Figure S2A ). The MS 3 spectrum at m/z 1465 (1742-1465) also gave the m/z 1261 fragment ion (Supplementary data, Figure S2B ). The m/z Figure S2C ). Thus, the structure of the molecular ion at m/z 1742 was assigned as the triglucosylated structure, Glc 3 Man 4 GlcNAc 1 . Similarly, the MS 2 spectrum of Hex 8 HexNAc 1 (m/z 1947) from agl-1(RNAi) gave fragment ions at m/z 1261 for Hex 6 and at m/z 708 for Hex 2 HexNAc 1 (Supplementary data, Figure S3 ). These fragment ions can only be produced from Glc 3 Man 5 GlcNAc 1 . Additionally, the Hex 7-8 HexNAc 2 FOSs were markedly increased in agl-1(RNAi) worms ( Figure 5B ) and MS n analysis revealed that most of these FOS-GN2 species were triglucosylated (data not shown). Thus, knockdown of agl-1 affects both the N-glycan profile and the FOS profile.
Discussion
The aim of this study was to understand the molecular basis of the consequence of ER α-glucosidase I deficiency. We identified the ER α-glucosidase I gene, agl-1, from C. elegans and subsequently knocked it down by RNAi. Unexpectedly, agl-1(RNAi) worms did not show any visible morphological or behavioral phenotypes, but life span was greatly reduced. To understand the effect of agl-1 knockdown on the N-linked glycome, we analyzed N-glycan as well as FOS profiles by MS and identified structural changes that are shared in eukaryotic α-glucosidase I-defective cells (Durrant and Moore 2002; Hong et al. 2004; Alonzi et al. 2008) . Our glycan profiling took advantage of permethylation to enhance sensitivity and suppress ionization differences between glycan structures, allowing us to obtain relative quantification of glycan changes based on MS signal intensities. The 36 N-glycans that we identified included oligomannosidic, paucimannosidic, truncated complex and Fuc-rich glycans. However, we did not detect PC-rich and native methylated glycans, due to methodological limitation of the permethylation protocol. The predominance of oligomannosidic and paucimannosidic glycans that we detected is in agreement with previous reports (Altmann et al. 2001; Cipollo et al. 2002 Cipollo et al. , 2005 Natsuka et al. 2002; Haslam and Dell 2003 ; α-Glucosidase I from Caenorhabditis elegans Paschinger et al. 2004; Hanneman et al. 2006; Schachter 2009 ). While glucosylated oligomannosidic glycans HexNAc 2 ) accounted for only 3.4% of the total N-glycan profile in the wild-type control, they increased to more than half of the total N-glycans (51%) in agl-1(RNAi). This increase indicates that agl-1 is critical to N-glycan processing.
Our glycomic analyses also identified a series of terminally dHex-modified (fucosylated) structures (dHex 1 Hex 9-12 Hex NAc 2 ) in agl-1(RNAi) animals, which accounted for more than 10% of the total N-glycan profile in the knockdown. MS n analyses revealed that the terminal dHex (Fuc) is attached to a Hex residue of C-branch of the glycan. Previous studies suggested that either Gal (Haslam and Dell 2003) or Man (Cipollo et al. 2002; Hanneman et al. 2006) can be the substrate for the fucosylation, and therefore, determining the Hex species on which fucosylation occurs in agl-1(RNAi) is necessary. Similar unusual fucosylation was previously reported in a C. elegans triple null mutant lacking UDP-GlcNAc:α-3-D-mannoside β1,2-N-acetylglucosaminyltransferase I (GnT-I) (gly-12, -13 and -14) as Fuc 1 Hex 6-9 HexNAc 2 (Zhu et al. 2004) . A shared feature detected both in this triple mutant and in agl-1(RNAi) worms is the reduction of native Fuc-rich structures. One possibility for the biological purpose of this unusual fucosylation is that they might be expressed to compensate for the loss of function of the usual Fuc-rich structures. Alternatively, decreased production of the usual Fuc-rich structures may free GDP-Fuc for use by other pathways. Identification and knockdown of the relevant fucosyltransferase(s) will be required in order to assess the functional consequences of these unusual glycans.
Cytosolic FOSs are potentially generated by three different enzymes: Pyrophosphatase acting on dolichol-linked oligosaccharides (Belard et al. 1988) , oligosaccharyltransferase (Anumula and Spiro 1983) and PNGase. Among these, PNGase is known to be involved in release of N-glycans from unfolded glycoproteins during ERAD. In yeast Saccharomyces cerevisiae, FOSs are undetectable in Δpng1 cells (Hirayama et al. 2010) , indicating that Png1p is the primary enzyme to generate FOSs. We have previously proved that most unfolded proteins were trafficked to the Golgi, based on the observations that M5A FOS-GN1 structure [Manα1-3(Manα1-6)Manα1-6(Manα1-3) Manα1-4GlcNAc] was the most abundant in wild-type and that GnT-1-processed FOS-GN1 structure (GlcNAc 1 Man 5 GlcNAc 1 ) was abundant in Golgi α-mannosidase II mutant worms. In this study, we detected paucimannosidic FOSs, Hex 2-3 HexNAc 1 , as more abundant FOS structures than Hex 5 HexNAc 1 in wild-type (control). This observation further corroborates the fact that unfolded glycoproteins retain within ER-Golgi compartments because paucimannosidic structures of N-glycan can be made in the Golgi by the action of a series of Golgi enzymes including GnT-I, Golgi α-mannosidase II and processing β-hexosaminidase. This observation also explains why triglucosylated FOSs detected in agl-1(RNAi), Hex 7-8 HexNAc 1-2 , possess a truncated α1,6-Man branch. Thus, most unfolded glycoproteins bearing triglucosylated N-glycans appear to be retained in the Golgi long enough to be acted on by α-mannosidase(s).
In our previous study, we failed to detect paucimannosidic Hex 2-3 HexNAc 1-2 glycans as major FOS structures, presumably because of technical limitations of the lectin-capture methodology used in that work (Kato, Kitamura et al. 2007) . In this work, we employed an unbiased collection method that was independent of the FOS structure. Therefore, the ratios of FOS species shown in this study are better indicators of the in vivo situation than those reported previously.
Knockdown of agl-1 caused a reduction of lifespan ( Figure 1C) . Caenorhabditis elegans mutants such as age-1 ( phosphatidylinositol-3-OH kinase) and daf-2 (insulin-like/ IGF-1 receptor) display an extended lifespan with an increased resistance to stress and a reduced metabolic rate (Morris et al. 1996; Kimura et al. 1997; Lin et al. 1997; Ogg et al. 1997) . It remains to be determined whether or not the glycan alterations in agl-1(RNAi) affects the activity of these previously described lifespan genes. In addition, deficiency of Mgat1 (GnT-1) gene in Drosophila melanogaster produced a severe reduction of lifespan (Sarkar et al. 2006) and, overexpression of GnT-1 in the mutant background not only rescued the shortened lifespan but actually increased lifespan (Sarkar et al. 2010) . Therefore, complex glycans appear to play an important regulatory role in determining the lifespan of invertebrates. However, mutants in one or more of the three C. elegans GnT-1 genes exhibit variable effects on viability, with the triple null exhibiting extended lifespan under conditions of stress (Zhu et al. 2004) . The differing extents of N-glycan processing that occur in various GnT-1 mutant backgrounds may generate unique phenotypes that depend on the specific cell expression patterns for each enzyme. Another report described that RNAi-based knockdown of the worm mans-1(D2030.1) that encodes the ortholog of Golgi α-mannosidase IA is associated with a 9% extension in mean lifespan (Liu et al. 2009 ). Since agl-1 acts upstream of GnT-1 and Golgi α-mannosidase I, the loss of α-glucosidase activity in affected worm cells results in a global blockage in the production of complex glycans at an earlier step in the N-glycan-processing pathway, thereby producing a greater shift in the glycan profile toward high Man structures. Identifying the glycoproteins that affect lifespan when aberrantly glycosylated will be important for understanding the underlying mechanisms.
ER stress has been shown to trigger autophagy to clear the unfolded proteins from the ER (Bernales et al. 2006; Yorimitsu et al. 2006) . We attempted to address whether autophagy was activated by knockdown of agl-1 by using an autophagy reporter protein, LGG-1::GFP (Melendez et al. 2003) . We only detected dots of LGG-1 expression throughout the body of agl-1(RNAi) worms and could not detect lipidation of LGG-1 (data not shown). Further experiments will be required to definitively determine whether autophagy contributes to the degradation of unfolded glycoproteins as well as the generation of FOSs in agl-1(RNAi) worms. It is known that several types of sugars can trigger autophagy. For example, we have found that the addition of amino sugars such as glucosamine to mammalian cells was able to induce autophagy (Shintani et al. 2010) . Also, the natural disaccharide trehalose was reported to be able to induce autophagy and accelerate the clearance of neurotoxic proteins in human cells (Sarkar et al. 2007; Casarejos et al. 2011) . In the present study, we demonstrated the accumulation of triglucosylated FOSs in the agl-1(RNAi) animals. Generally, in mammalian cells, cytosolic FOSs are cleared from the cytosol by a lysosomal FOS transporter in an ATP-dependent manner. The transport of FOSs into the lysosomes is dependent T Katoh et al. on their structures (Man 3 GlcNAc > Man 4 GlcNAc > Man 5 GlcNAc >> Man 9 GlcNAc); FOS-phosphate are not transported (Saint-Pol et al. 1999) . Triglucosylated FOSs were shown to be poor substrates for the lysosomal FOS transporter in HepG2 cells and mouse lymphoma HL60 cells (Moore and Spiro 1994; Mellor et al. 2004) . Therefore, glucosylated FOSs is probably not able to gain access into the lysosome through the canonical lysosomal FOS transporter. However, triglucosylated FOSs do not accumulate in the cytosol of CHO Lec23 cells, which lack ER α-glucosidase I, but are cleared from the cells by an as yet undefined mechanism (Durrant and Moore 2002) .
Although not yet investigated, we predict that autophagy is activated in these cells in response to the presence of glucosylated FOSs, providing an alternative route for elimination of these glycans. Full appreciation of the consequences of ER α-glucosidase I deficiency will require further investigation into whether glucosylated FOSs trigger autophagy in any system. The generation and characterization of the agl-1(RNAi) animals reported here provides a platform for future studies.
Materials and methods
Strains and culture of nematode The N2 Bristol strain was used as the wild-type. Transgenic strain SJ4005, zcIs4[hsp-4::GFP]V (Calfon et al. 2002) was obtained from the Caenorhabditis Genetics Center. The strains were maintained at 20°C on nematode growth media (NGM) agar plates with E. coli OP50 as a food (Brenner 1974) .
Cloning of agl-1 and construction of plasmids Total cDNAwas synthesized from total RNA extracted from the wild-type using ReverTra Ace-plus-reverse transcriptase (Toyobo, Japan). The agl-1 cDNA was amplified by PCR using KOD-plus-DNA polymerase (Toyobo) and the following pair of primers, 5′-CAAGTCGACATGCACAGGGAACATGAAG AG-3′ and 5′-AAAAGCGGCCGCCTAAGTGTCCAAGTTA TCAC-3′. The 2.5 kbp PCR product was digested with SalI and NotI, and inserted to pME/FLAG vector to express N-terminally FLAG-tagged AGL-1.
Fluorescence-activated cell sorting CHO Lec23 cells provided from Prof. P. Stanley were transiently transfected with either pME/FLAG-agl-1 or mock plasmid, and cultured for 2 days in HAM-12 medium supplemented with 10% fetal calf serum. Cells were harvested and stained with FITC-conjugated L 4 PHA lectin (J-Oil Mills, Japan) for 15 min at 4°C, and analyzed by fluorescence-activated cell sorting (FACS) Vantage (BD Bioscience, CA).
Knockdown of agl-1 by feeding RNA interference Feeding RNAi for agl-1 gene expression in C. elegans was carried out as described (Kamath et al. 2000) . The E. coli HT115 (DE3) harboring RNAi plasmid L4440 or L4440/F13H10.4 (Gene Service, UK) were cultured overnight in Luria-Bertani (LB) medium containing 100 µg/mL ampicillin at 37°C and spotted onto NGM plate supplemented with 25 µg/mL carbenicillin and 1 mM Isopropyl β-D-1-thiogalactopyranoside. L4 worms were transferred onto plates and cultured at 20°C, and the next generation was analyzed. HT115 harboring a mock plasmid L4440 was used for the control. To assess knockdown efficiency, semi-quantitative RT-PCR was performed as follows: Total RNA was extracted with Sepasol RNA I Super (Nacalai Tesque, Japan) from worms frozen in liquid nitrogen and the RNA was then treated with RQ RNase-free DNase (Promega, WI) to digest genomic DNA. Total cDNA was obtained with ReverTra Ace-plus-(Toyobo) and poly dT-primer from the total RNA as template. Using the total cDNA as a template, PCR was performed with Taq polymerase and primer sets, 5′-TAACGAGAAGCACAACGACG-3′ and 5′-GCTTCCGATC CAACAATCAT-3′ for agl-1, and 5′-TGTGTGACGACGAGGT TG-3′ and 5′-AGAAGCACTTGCGGTGAACGA-3′ for act-1.
Determination of lifespan
Worms were synchronized and young adults were treated with 0.5 mg/mL fluorodeoxyuridine (Sigma-Aldrich, MO) to prevent their progeny from developing. After 24 h, seven worms were transferred to RNAi plates and cultured at 20 or 25°C. Ten plates (total 70 worms) were used for each test.
Western blotting for anti-HRP epitope Proteins were separated by SDS-PAGE on 12.5% gels and transferred to polyvinylidene fluoride membrane. After blocking with 0.5% bovine serum albumin, membranes were incubated with rabbit anti-HRP (1:12,500, Sigma-Aldrich), and then with HRP-conjugated anti-rabbit IgG (1:2000, Santa Cruz Biotechnology, CA). Detection was carried out using SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific, IL), followed by development on X-ray films.
Extraction of FOSs from worms N2 worms fed with bacteria expressing double-stranded RNA of agl-1 or bacteria harboring control vector on plates were harvested and washed with phosphate-buffered saline. Approximately 100 µL of worms were used for FOS and N-glycan analysis. Worms were homogenized in extraction buffer consisting of 20 mM of HEPES ( pH 7.6), 150 mM NaCl, 1 mM EDTA, 1 mM MgCl 2 , 1 mM CaCl 2 , complete protein inhibitor cocktail (Roche, Switzerland) on ice. Worm debris and large organelles were removed by spinning down for 10 min at 5000 × g. Membrane fractions were further separated by ultracentrifugation (106,000 × g, 45 min). One milliliter of cytosolic fraction was used for subsequent analysis. Each protein concentration was assayed with micro BCA protein assay kit (Thermo Scientific). After removing proteins by acetone precipitation, the supernatants were evaporated to dryness. Salts were removed by passing through AG50 resin. FOSs were further purified by using C18 cartridge column (JT Baker, NJ). Pass-through fractions of the C18 column were lyophilized and subjected to derivatization and analysis.
Extraction of glycoproteins from C. elegans and release of N-glycans After separation of cytosol fraction, pellets of worm debris and organelles and of membrane protein fraction were combined. Proteins were precipitated in 80% acetone twice and in 100% α-Glucosidase I from Caenorhabditis elegans acetone once. They were subsequently denatured by boiling for 5 min and digested with trypsin (Sigma-Aldrich) and chymotrypsin (Sigma-Aldrich) in 0.1 M Tris-HCl ( pH8.2), 10 mM CaCl 2 . The resultant glycopeptides were dried, reconstituted in 5% acetic acid, loaded onto a C18 column preequilibrated with 5% acetic acid. After washing the C18 column with 5% acetic acid, the glycopeptides were eluted by 20% 2-propanol in 5% acetic acid followed by 40% 2-propanol in 5% acetic acid. The eluted glycopeptides were combined and dried. N-Glycans were released by hydrazinolysis followed by re-N-acetylation as described previously (Patel et al. 1993 ). Glycans were purified by passing through a Dowex 50WX8 (H + form, Sigma-Aldrich) and C18 column, lyophilized, and subjected to permethylation.
Analysis of glycans by NSI-MS
n Purified FOSs and N-glycans were permethylated for enhancement of sensitivity and structural determination by MS (Anumula and Taylor 1992) . NSI-MS n analysis of permethylated glycans was performed as previously described (Aoki et al. 2007 ). Permethylated glycans were dissolved in 1 mM sodium hydroxide in 50% methanol and infused directly into a linear ion trap/orbitrap FT mass spectrometer (LTQ-Orbitrap Discovery, Thermo Scientific) using a nanoelectrospray source at a syringe flow rate of 0.40 µL/min. MS analysis was performed in positive ion mode. For fragmentation by CID in MS/MS and MS n modes, 35-45% collision energy was applied. The total ion mapping functionality of the Xcalibur software package (version 2.0.7) was performed to obtain MS/MS data for the total glycan profiles. Automated MS and MS/MS spectra were obtained in collection windows that were 2.8 mass units in width. Five scans, each 150 ms in duration, were averaged for each collection window. The m/z range from 600 to 2000 was scanned in successive 2.8 mass unit windows with a window-to-window overlap of 0.8 mass units. Glycan prevalence was calculated as % of total profile where the total profile was taken as the sum of the peak intensities for all quantified glycans.
Assays for ER stress induction
For ER stress assay, transgenic worm strain SJ4005 was used. As a positive control for induction of ER stress, SJ4005 was cultured on 2.5 µg/mL TM-containing NGM plates (Calfon et al. 2002) . For microscopic analyses, worms were transferred in a drop of 10 mM sodium azide on a 2% agarose pad and fluorescence was observed using a fluorescent microscope (Olympus, Japan) with an exposure time of 0.5 s. Western blotting of tagged GFP was performed with anti-GFP (MBL, Japan) as a primary antibody.
Supplementary data
Supplementary data for this article are available online at http:// glycob.oxfordjournals.org/.
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